Next-Generation Integrase Inhibitors: Where to After Raltegravir?
Next-Generation Integrase Inhibitors: Where to After Raltegravir?
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing AG
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing AG
Subjects
More information
Scope and Contents
Contents
The integrase enzyme facilitates the incorporation of HIV-1 proviral DNA into the host cell genome and catalyses a function vital to viral replication. Inhibitors of this enzyme represent the newest class of antiretroviral drugs in our armamentarium to treat HIV-1 infection. Raltegravir, an integrase strand transfer inhibitor, was the first drug of...
Alternative Titles
Full title
Next-Generation Integrase Inhibitors: Where to After Raltegravir?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1466148633
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1466148633
Other Identifiers
ISSN
0012-6667
E-ISSN
1179-1950
DOI
10.1007/s40265-013-0015-5
